Carl-Friedrich C.
- Country
- Germany
- Department
- Universitäts-Kinder- und Jugendklinik K1
Research Overview
- International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- International cooperative prospective study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the efficacy of Vinblastine
- Reduced‑intensity post‑induction chemotherapy plus blinatumomab versus standard post‑induction therapy in pediatric standard‑risk B‑ALL (AIEOP‑BFM ALL 2025)
Data & Insights
Has run more than one trial at 264 of 366 partner sites.
Specializations
Hematologic Oncology
The investigator demonstrates extensive experience in treating acute lymphoblastic leukemia and acute myeloid leukemia, with particular focus on pediatric and adolescent populations. Their research extends to specialized areas including Down syndrome-associated myeloid leukemia and B-cell lymphomas.
- Leukemia variants
- Lymphoma treatments
- Novel therapeutic approaches
Solid Tumors
Expertise encompasses various pediatric solid tumors, including rhabdomyosarcoma, Ewing sarcoma, and germ cell tumors. The investigator works with both localized and metastatic disease presentations, implementing multimodal treatment approaches.
- Sarcoma management
- Tumor response assessment
- Combined therapy protocols
Neuro-Oncology
Specialized focus on central nervous system tumors, particularly medulloblastoma and ependymoma. The investigator's work involves comprehensive treatment strategies incorporating surgical, radiation, and chemotherapy approaches.
- Brain tumor protocols
- Risk-adapted therapies
- Treatment optimization
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.